1.Opie, L. H. (2007). Acute myocardial infarction and diabetes. Lancet. 370: 634-5.
2.El-Menyar, A. A., M. M. Gomaa, et al. (2006). "Obesity: a risk factor for acute myocardial infarction with angiographically patent epicardial coronary vessels in an adolescent." Med Princ Pract 15(6): 449-52.
3.行政院衛生署 (2007)‧民國九十六年台灣地區主要死亡原因。
4.蔡岡廷,邱千芳,蘇世斌,李聰明:年輕人的急性心肌梗塞之一的病例報告。基層醫學2006,21(10):6。5.Ehtisham, A., M. I. Chimowitz, et al. (2005). "Systemic risk factors associated with progression of atherosclerosis from the coronary to the carotid arteries." J Stroke Cerebrovasc Dis 14(4): 182-5.
6.Lusis AJ.2000.Atherosclerosis.Nature 407:233-41
7.Liuzzo, G. (2001). "Atherosclerosis: an inflammatory disease." Rays 26(4): 221-30.
8.Maxwell, S. R. and G. Y. Lip (1997). "Free radicals and antioxidants in cardiovascular disease." Br J Clin Pharmacol 44(4): 307-17.
9.Huang ,H., W. Mai, et al (2008). "The oxidation ratio of LDL :a predictor for coronary artery disease. " Dis Markers 24(6):341-9.
10.Keaney, J. F., Jr. (2000). "Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction." Mol Aspects Med 21(4-5): 99-166.
11.Corrado, E. and S. Novo (2005). "Role of inflammation and infection in vascular disease." Acta Chir Belg 105(6): 567-79.
12.Jairath N. Coronary heart disease and risk factor management: A nursing perspective. 1st ed. Philadelphia: W.B. Saunders Company; 1999.
13.Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990''s. Nature 1993;362(29):801-809.
14.Benditt EP. The origin of atherosclerosis. Sci Am 1977;236(2):74-85.
15.Velican C, Velican D. Natural history of coronary atherosclerosis. 1st ed. Boca Raton: CRC Press; 1989.
16.Fuster V, Badimon L, Badimon JJ and Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-250.
17.Friedman M. Pathogenesis of coronary atherosclerosis disease. 1st ed. New York: McGraw-Hill; 1969.
18.Glagov S, Zarins C, Gidden DP and Ku DN. Hemodynamics and atherosclerosis. Arch Pathol Lab Med 1988;112:1018-1031.
19. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82(3)(Suppl II):3846.
20.Harpaz, D., S. Behar, et al. (2004). "Family history of coronary artery disease and prognosis after first acute myocardial infarction in a national survey." Cardiology 102(3): 140-6.
21.Huang, H., W. Mai, et al. (2008). "The oxidation ratio of LDL: a predictor for coronary artery disease." Dis Markers 24(6): 341-9.
22.Washio, M. and R. Hayashi (2004). "Past history of obesity (overweight by WHO criteria) is associated with an increased risk of nonfatal acute myocardial infarction: a case-control study in Japan." Circ J 68(1): 41-6.
23.DiLeo, M. V., J. A. Kellum, et al. (2009). "A simple mathematical model of cytokine capture using a hemoadsorption device." Ann Biomed Eng 37(1): 222-9.
24.Grau, A. J., M. Aulmann, et al. (2001). "Increased cytokine release by leucocytes in survivors of stroke at young age." Eur J Clin Invest 31(11): 999-1006.
25.Saadeddin, S. M., M. A. Habbab, et al. (2002). "Markers of inflammation and coronary artery disease." Med Sci Monit 8(1): RA5-12.
26.Mazurek, T., L. Zhang, et al. (2003). "Human epicardial adipose tissue is a source of inflammatory mediators." Circulation 108(20): 2460-6.
27.Ehara, S., T. Naruko, et al. (2008). "Small coronary calcium deposits and elevated plasma levels of oxidized low density lipoprotein are characteristic of acute myocardial infarction." J Atheroscler Thromb 15(2): 75-81.
28.Pepys, M. B. and A. Berger (2001). "The renaissance of C reactive protein." Bmj 322(7277): 4-5.
29.Lindahl, B., H. Toss, et al. (2000). "Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease." N Engl J Med 343(16): 1139-47.
30.Halil, M., B. Yavuz, et al. (2008). "Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score." J Cardiovasc Med (Hagerstown) 9(7): 683-7.
31.de Ferranti, S. D. and N. Rifai (2007). "C-reactive protein: a nontraditional serum marker of cardiovascular risk." Cardiovasc Pathol 16(1): 14-21.
32.Zwaka, T. P., V. Hombach, et al. (2001). "C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis." Circulation 103(9): 1194-7.
33.Bautista, L. E., I. A. Arenas, et al. (2002). "Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies." J Clin Epidemiol 55(9): 882-7.
34.Splaver, A., G. A. Lamas, et al. (2004). "Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials." Am Heart J 148(1): 34-40.
35.Nygard, O., J. E. Nordrehaug, et al. (1997). "Plasma homocysteine levels and mortality in patients with coronary artery disease." N Engl J Med 337(4): 230-6.
36.Russell, J. C. and S. D. Proctor (2006). "Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis." Cardiovasc Pathol 15(6): 318-30.
37.Benson, V., A. C. McMahon, et al. (2007). "ICAM-1 in acute myocardial infarction: a potential therapeutic target." Curr Mol Med 7(2): 219-27.
38.Hansson, G. K., P. Libby, et al. (2002). "Innate and adaptive immunity in the pathogenesis of atherosclerosis." Circ Res 91(4): 281-91.
39.Satoh, M., Y. Ishikawa, et al. (2008). "Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease." Atherosclerosis 198(2): 347-53.
40.Libby, P. (2002). "Inflammation in atherosclerosis." Nature 420(6917): 868-74.
41.Ross, R. (1999). "Atherosclerosis--an inflammatory disease." N Engl J Med 340(2): 115-26.
42.Hegyi, L., J. N. Skepper, et al. (1996). "Foam cell apoptosis and the development of the lipid core of human atherosclerosis." J Pathol 180(4): 423-9.
43.Shah, P. K. (2003). "Pathophysiology of plaque rupture and the concept of plaque stabilization." Cardiol Clin 21(3): 303-14, v.
44.Tang, Z. H., N. P. Wang, et al. (2007). "[Roles of shear stress in atherogenesis]." Sheng Li Ke Xue Jin Zhan 38(1): 37-42.
45.Chien, S. (2008). "Role of shear stress direction in endothelial mechanotransduction." Mol Cell Biomech 5(1): 1-8.
46.Corrado, E. and S. Novo (2005). "Role of inflammation and infection in vascular disease." Acta Chir Belg 105(6): 567-79.
47.Brown, M. D., T. M. Wick, et al. (2001). "Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells." Pediatr Pathol Mol Med 20(1): 47-72.
48.Maier, W., L. A. Altwegg, et al. (2005). "Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein." Circulation 111(11): 1355-61.
49.Ginsburg, I. (2002). "The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae." Apmis 110(11): 753-70.
50.Hanada, T. and A. Yoshimura (2002). "Regulation of cytokine signaling and inflammation." Cytokine Growth Factor Rev 13(4-5): 413-21.
51.Calixto, J. B., M. F. Otuki, et al. (2003). "Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB)." Planta Med 69(11): 973-83.
52.Calixto, J. B., M. M. Campos, et al. (2004). "Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules." Planta Med 70(2): 93-103.
53.Jialal, I., S. Devaraj, et al. (2002). "Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy." Free Radic Res 36(12): 1331-6.
54.. Laude, K., V. Richard, et al. (2004). "Coronary endothelial cells: a target of ischemia reperfusion and its treatment?" Arch Mal Coeur Vaiss 97(3): 250-4.
55.Berk, B. C., J. I. Abe, et al. (2001). "Endothelial atheroprotective and anti-inflammatory mechanisms." Ann N Y Acad Sci 947: 93-109; discussion 109-11.
56.Platanias, L. C. and N. J. Vogelzang (1990). "Interleukin-1: biology, pathophysiology, and clinical prospects." Am J Med 89(5): 621-9.
57.El-Omar, E. M. (2001). "The importance of interleukin 1beta in Helicobacter pylori associated disease." Gut 48(6): 743-7.
58.Pomianek, M. J., C. K. Colton, et al. (1996). "Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress." Asaio J 42(1): 52-9.
59.Gogusev, J., S. Barbey, et al. (1996). "Regulation of TNF-alpha and IL-1 gene expression during TPA-induced differentiation of "Malignant histiocytosis" DEL cell line t(5;6) (q35:p21)." Anticancer Res 16(1): 455-60.
60.Calcagni, E. and I. Elenkov (2006). "Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases." Ann N Y Acad Sci 1069: 62-76.
61.Dinarello, C. A. (1996). "Biologic basis for interleukin-1 in disease." Blood 87(6): 2095-147.
62.Mastruzzo, C., N. Crimi, et al. (2002). "Role of oxidative stress in pulmonary fibrosis." Monaldi Arch Chest Dis 57(3-4): 173-6.
63.Berger, M., S. Budhu, et al. (2002). "Different G(i)-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils." J Leukoc Biol 71(5): 798-806.
64.Cavanaugh, P. F., Jr., M. P. Meredith, et al. (1998). "Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse." J Periodontal Res 33(2): 75-82.
65.Raivich, G., M. Bohatschek, et al. (2003). "Lymphocyte infiltration in the injured brain: role of proinflammatory cytokines." J Neurosci Res 72(6): 726-33.
66..Dinarello, C. A. (1996). "Cytokines as mediators in the pathogenesis of septic shock." Curr Top Microbiol Immunol 216: 133-65.
67.Bromander, A., J. Holmgren, et al. (1991). "Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro." J Immunol 146(9): 2908-14.
68.Tong, L., R. Balazs, et al. (2008). "Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction." Neurobiol Aging 29(9): 1380-93.
69.Nakamura, C., Y. Fukutomi, et al. (1997). "Dharmendra antigen but not integral M. leprae is an efficient inducer of immunostimulant cytokine production by human monocytes, and M. leprae lipids inhibit the cytokine production." Int J Lepr Other Mycobact Dis 65(1): 63-72.
70.Fantuzzi, G., D. A. Reed, et al. (1999). "IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor." J Clin Invest 104(6): 761-7.
71..Balkwill, F. R. (1989). "Tumour necrosis factor." Br Med Bull 45(2): 389-400.
72.Tseng, L. H., P. J. Chen, et al. (2001). "Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1 beta and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese." Tissue Antigens 57(4): 318-24.
73.DeGraba, T. J. (1998). "The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy." Neurology 51(3 Suppl 3): S62-8.
74.Rothwell, N., S. Allan, et al. (1997). "The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications." J Clin Invest 100(11): 2648-52.
75.Rothwell, N. J. and G. N. Luheshi (2000). "Interleukin 1 in the brain: biology, pathology and therapeutic target." Trends Neurosci 23(12): 618-25.
76.Dinarello, C. A. (1996). "Cytokines as mediators in the pathogenesis of septic shock." Curr Top Microbiol Immunol 216: 133-65.
77.Stevenson, F. T., F. Torrano, et al. (1992). "Interleukin 1: the patterns of translation and intracellular distribution support alternative secretory mechanisms." J Cell Physiol 152(2): 223-31.
78.Kato, Z., J. Jee, et al. (2003). "The structure and binding mode of interleukin-18." Nat Struct Biol 10(11): 966-71.
79.Zhang, D. L., H. M. Zheng, et al. (2005). "Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock." World J Gastroenterol 11(28): 4409-13.
80.Huang, D., R. Pirskanen, et al. (1998). "Polymorphisms in IL-1beta and IL-1 receptor antagonist genes are associated with myasthenia gravis." J Neuroimmunol 81(1-2): 76-81.
81.Pociot, F., J. Molvig, et al. (1992). "A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro." Eur J Clin Invest 22(6): 396-402.
82.Chen, Y. L., Y. L. Huang, et al. (2006). "Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells." Biochem Biophys Res Commun 346(1): 160-8.
83.Robert, A., E. Saperas, et al. (1991). "Gastric cytoprotection by intracisternal interleukin-1 beta in the rat." Biochem Biophys Res Commun 174(3): 1117-24.
84.El-Omar, E. M., M. Carrington, et al. (2000). "Interleukin-1 polymorphisms associated with increased risk of gastric cancer." Nature 404(6776): 398-402.
85.Mazuski, J. E., K. Tolman, et al. (1997). "Effects of cytokine antagonists on the hepatic acute-phase response." J Surg Res 68(2): 161-9.
86.Wang, C., M. W. Wang, et al. (2005). "Evodiamine induced human melanoma A375-S2 cell death partially through interleukin 1 mediated pathway." Biol Pharm Bull 28(6): 984-9.
87.Wiegmann, K., R. Schwandner, et al. (1999). "Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase." J Biol Chem 274(9): 5267-70.
88.Mabuchi, T., K. Kitagawa, et al. (2000). "Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats." Stroke 31(7): 1735-43.
89.Jin, Z. and W. S. El-Deiry (2006). "Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis." Mol Cell Biol 26(21): 8136-48.
90..Wang, L. X., M. Ideishi, et al. (2001). "Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury." Hypertens Res 24(2): 179-87.
91.Camargo, M. C., R. Mera, et al. (2006). "Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis." Cancer Epidemiol Biomarkers Prev 15(9): 1674-87.
92.Beales, I. L. and J. Calam (1998). "Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways." Gut 42(2): 227-34.
93.Al-Moundhri, M. S., M. Al-Nabhani, et al. (2006). "Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population." Gastric Cancer 9(4): 284-90.
94.Machado, J. C., P. Pharoah, et al. (2001). "Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma." Gastroenterology 121(4): 823-9.
95.Elhage, R., A. Maret, et al. (1998). "Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice." Circulation 97(3): 242-4.
96.Aziz, A. (2006). "A study on immunopathogenetic mechanisms of atherosclerotic process caused by chronic infection of Chlamydia pneumoniae in rats (Ratus novergicus)." Acta Med Indones 38(4): 206-12.
97.Mrak, R. E. and W. S. Griffin (2000). "Interleukin-1 and the immunogenetics of Alzheimer disease." J Neuropathol Exp Neurol 59(6): 471-6.
98.Minster, R. L., S. T. DeKosky, et al. (2000). "Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer''s disease." Ann Neurol 48(5): 817-9.
99.Schubert, P., T. Morino, et al. (2000). "Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling." Ann N Y Acad Sci 903: 24-33.
100.Witkin, S. S., S. Gerber, et al. (2002). "Influence of interleukin-1 receptor antagonist gene polymorphism on disease." Clin Infect Dis 34(2): 204-9.
101.IKimya, Y., C. Akdis, et al. (1997). "Plasma interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist levels in pre-eclampsia." Eur J Obstet Gynecol Reprod Biol 73(1): 17-21.
102.Bortolami, M., A. Kotsafti, et al. (2008). "Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease." J Viral Hepat 15(7): 515-22.
103.Manzoli, A., F. Andreotti, et al. (1999). "Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease." Cardiologia 44(9): 825-30.
104.Byrne, C. E., A. Fitzgerald, et al. (2004). "Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes." BMC Med Genet 5: 13.
105.Chou, H. T., C. H. Tsai, et al. (2005). "Lack of association of genetic polymorphisms in the interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese." Int Heart J 46(3): 397-406.
106.Li, B., Y. H. Liao, et al. (2006). "Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction." Int J Cardiol 111(2): 247-55.
107.Oda, K., N. Tanaka, et al. (2007). "Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases." Hum Mol Genet 16(6): 592-9.
108.Arman, A., O. Soylu, et al. (2008). "Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease." Arq Bras Cardiol 91(5): 293-8.
109.Geismar, K., C. Enevold, et al. (2008). "Involvement of Interleukin-1 Genotypes in the Association of Coronary Heart Disease With Periodontitis." J Periodontol 79(12): 2322-2330.
110.Carter, K. W., J. Hung, et al. (2008). "Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population." Hum Genet 124(3): 199-206.
111.Lin, R. C. and B. J. Morris (2002). "Association analysis of polymorphisms at the interleukin-1 locus in essential hypertension." Am J Med Genet 107(4): 311-6.